Sexual Dysfunction Clinical Trial
Official title:
A Pilot Study to Determine the Degree and Effectiveness of the Various Operating Modes of vSculpt on Enhancing Genital Blood Flow and Improving Quality of Life in Women Who Experience Sexual Dysfunction and Stress Incontinence
NCT number | NCT02856490 |
Other study ID # | JOY 1515-02 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | July 2016 |
Est. completion date | December 2016 |
Verified date | August 2016 |
Source | Joylux, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A pilot study to determine the degree and effectiveness of the various modes of vSculpt, an over-the-counter "OTC" medical device, on enhanced genital blood flow and improvement in quality of life in menopausal women who suffer sexual dysfunction and stress incontinence
Status | Completed |
Enrollment | 6 |
Est. completion date | December 2016 |
Est. primary completion date | December 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 48 Years to 60 Years |
Eligibility | Inclusion Criteria: - Study participants will be female - Female participants who are capable of giving informed consent - Female participants who are menopausal who have not had a menses within one year, and are within the ages of 48 and 60 - Female participants who have had one or more vaginal births - Female participants who are currently engaged in vaginal sexual intercourse with a partner - Female participants who are presently experiencing bladder control issues either leakage, frequency or urgency - Female participants who are presently experiencing pain during sexual intercourse Exclusion Criteria: - Female participants shall not have an active sexually transmitted disease and/or infection - Female participants who are actively undergoing chemotherapy - Female participants who are currently taking any cancer-related drugs - Female participants who are breastfeeding or lactating - Female participants who have a medical history of neurological disorders (e.g., multiple sclerosis, Parkinson's disease) - Female participants with an active urinary tract infection (UTI) - Female participants with active bladder stones - Female participants with active bladder tumor(s) - Females with prior laser or vaginal rejuvenation surgeries or treatments - Females with a medical history of vaginal cancer or radiation or surgery with exception of related to childbirth - Females with prior non-invasive treatments (estrogen cream) or pelvic floor physical therapy for the vaginal area/ pelvic floor in the past six month - Females with a physical disability precluding her from holding a lithotomy for an hour - Females who are homeless |
Country | Name | City | State |
---|---|---|---|
United States | San Diego Sexual Medicine | San Diego | California |
Lead Sponsor | Collaborator |
---|---|
Joylux, Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Blood Flow as Measured by Temperature Change in the Genitalia Using Thermography Technology | The primary outcomes assessed will be change in blood flow as measured by temperature change in Celsius in the genitalia using thermography technology. | Pre and post treatment at baseline and pre and post treatment at day 30 | |
Secondary | Patient Quality of Life as Measured by Female Sexual Function Index (FSFI) Scores at Baseline and 30 Days Post Treatment. | Change in patient quality of life as measured by an improvement in Female Sexual Function Index (FSFI) scores at baseline and 30 days post treatment. The range being from 2 (minimum) to 36 (maximum), with maximum being better. | Baseline and 30 days | |
Secondary | Patient Quality of Life as Measured by Female Sexual Distress Scores (FSDS) at Baseline and 30 Days Post Treatment. | Change in patient quality of life as measured by an improvement in Female Sexual Distress Scores (FSDS) at baseline and 30 days post treatment. The range being from 0 (minimum) to 52 (maximum), with minimum being better. | Baseline and 30 days | |
Secondary | Patient Quality of Life as Measured by the Urogenital Distress Inventory, Short Form (UDI-6) | Change in patient quality of life as measured by an improvement in Urogenital Distress Inventory, Short Form (UDI-6) scores. The range being from 0 (minimum) to 100 (maximum), with minimum being better. | Baseline and 30 days | |
Secondary | Patient Quality of Life as Measured by the Incontinence Impact Questionnaire, Short Form (IIQ-7) | Change in patient quality of life as measured by an improvement in Incontinence Impact Questionnaire, Short Form (IIQ-7) scores. The range being from 0 (minimum) to 100 (maximum), with minimum being better. | Baseline and 30 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039775 -
Clitoral Therapy Device in Alleviating Sexual Dysfunction After Genital Mutilation.
|
N/A | |
Recruiting |
NCT05380856 -
Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction
|
N/A | |
Not yet recruiting |
NCT05918770 -
Side Effects Screening and Early Intervention to Impact in Quality of Life of Gynaecological Cancer Patients
|
N/A | |
Completed |
NCT02430987 -
Low Sexual Desire and Metabolic Syndrome
|
N/A | |
Completed |
NCT02096783 -
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer
|
N/A | |
Completed |
NCT02837796 -
Effects of Trans-Obturator Tape outside-in Versus Inside-out Procedure for Stres Urinary Incontinence
|
N/A | |
Completed |
NCT01434290 -
Radiation Therapy in Treating Patients With Prostate Cancer
|
Phase 2 | |
Completed |
NCT01660152 -
Vacuum Erection Device in Improving Recovery of Erectile Function in Patients With Prostate Cancer Undergoing Surgery
|
N/A | |
Active, not recruiting |
NCT00981305 -
Impact of Lactate-Containing Vaginal Lubricant on Sexual Dysfunction in Young Breast Cancer Survivors
|
Phase 3 | |
Completed |
NCT04964895 -
Sexual Quality of Patients After Bladder Cancer Cystectomy
|
N/A | |
Enrolling by invitation |
NCT05832268 -
Pelvic Floor Function After Obstetric Injury to the Anal Sphincter
|
||
Completed |
NCT04066218 -
Sexual Function Screening in Childhood Cancer Survivors
|
||
Not yet recruiting |
NCT05530681 -
Correlation Pelvic Floor Function and Ultrasound Findings One Year After Childbirth
|
N/A | |
Recruiting |
NCT05826691 -
Benign Prostate Surgery and QOL and Sexual Function
|
||
Completed |
NCT04560283 -
HYDEAL-D® Application for Promoting the Restoration of Sexual Function in the Postpartum Period
|
Phase 4 | |
Completed |
NCT03232801 -
A Mindfulness-based Intervention for Older Women With Low Sexual Desire
|
N/A | |
Suspended |
NCT04544735 -
Improving Women's Function After Pelvic Radiation
|
N/A | |
Completed |
NCT05732844 -
Efficacy of the Use of Vaginal Balls for the Improvement of Urinary Incontinence and Sexual Function in Women.
|
N/A | |
Recruiting |
NCT05097469 -
Carbon Dioxide Acupulse Laser Treatment Versus Sham Treatment and Sexual Dysfunction.
|
N/A | |
Withdrawn |
NCT01635543 -
Investigation of Sexual Function in Crohn's Disease Patients With Perianal Fistulas
|
N/A |